Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is ...

Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Greetings, and welcome to TG Therapeutics First Quarter Conference ...

Gerald Voelbel, 57, a cognitive neuroscientist, awoke with double vision, a migraine, and coordination issues—symptoms that led to two unexpected diagnoses.

Halozyme Therapeutics, Inc. ( NASDAQ: HALO) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Tram Bui - Vice President, Investor Relations & Corporate Communications Helen Torley - President & ...

Learn about eye changes that could indicate serious health conditions, from blurry vision to persistent floaters and flashes ...

The Food and Drug Administration (FDA) has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older who are ...

Last year, the FDA placed a partial clinical hold on tolebrutinib phase 3 trials in MS and myasthenia gravis after cases of drug-induced liver injury were observed, with recruitment of new studies ...

The FDA has approved Alexion's Soliris for use in patients with treatment resistant generalised Myasthenia gravis (gMG), making ... a tumultuous one for Alexion, after its chief executive and ...

Amgen's diverse portfolio ensures stability, but risks like high debt and biosimilar competition loom. Check out my look at ...

The FDA approved Johnson & Johnson’s nipocalimab, which is also being studied as a potential treatment in HDFN, in myasthenia ...

Trevor McEuen was due in court on Monday for a murder charge. A murder suspect is on the loose in north Texas after allegedly removing his ankle monitor before a court appearance, according to the ...